scispace - formally typeset
M

Mieke R. Van Bockstal

Researcher at Université catholique de Louvain

Publications -  12
Citations -  130

Mieke R. Van Bockstal is an academic researcher from Université catholique de Louvain. The author has contributed to research in topics: Ductal carcinoma & Breast cancer. The author has an hindex of 4, co-authored 12 publications receiving 57 citations. Previous affiliations of Mieke R. Van Bockstal include Cliniques Universitaires Saint-Luc & Ghent University.

Papers
More filters
Journal ArticleDOI

The Impact of the COVID-19 Pandemic and the Associated Belgian Governmental Measures on Cancer Screening, Surgical Pathology and Cytopathology.

TL;DR: The anti-COVID-19 measures significantly diminished all screening-related samples, and strongly reduced the number of samples related to “functional” pathology, such as thyroidectomies and gastric biopsies, which seemed largest for cancer screening.
Journal ArticleDOI

Interobserver Variability in Upfront Dichotomous Histopathological Assessment of Ductal Carcinoma in Situ of the Breast: The DCISion Study

TL;DR: The interobserver variability among 39 pathologists who performed upfront dichotomous evaluation of 149 consecutive ductal carcinomas in situ is at most acceptable, although it varies among the different histopathological features.
Journal ArticleDOI

The Liver in COVID-19-Related Death: Protagonist or Innocent Bystander?

TL;DR: It was concluded that COVID-19 infection was not associated with a specific histopathological pattern of the liver, and the main histological changes can be explained by the hypoxic status as a result of severe hypoxemic pneumonia leading to death.
Journal ArticleDOI

Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer.

TL;DR: This retrospective study of a consecutive community-based cohort of TNBC patients confirms that sTILs are a robust, observer-independent predictor for therapeutic response after NAC and the combination of Sox10, GATA3 and p53 immunoreactivity is unlikely to harbor any predictive value for pCR in TNBC.
Journal ArticleDOI

Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast.

TL;DR: In this paper, the authors evaluated the INSM1 expression in a consecutive series of 66 invasive breast cancer biopsies and concluded that neuroendocrine differentiation in invasive breast carcinoma of no special type is a rare finding.